What if the journey to parenthood could be made faster, safer, and less physically taxing? Gameto, a biotechnology startup company, has made this dream a reality with its revolutionary Fertilo procedure. The world’s first live birth using its in-vitro fertilization technique, Fertilo marks a significant milestone in reproductive medicine. This groundbreaking delivery took place at Santa Isabel Clinic in Lima, Peru, demonstrating the immense potential of ovarian support cell (OSC) technology.
A Revolutionary Approach to IVF
Fertilo represents a paradigm shift in assisted reproductive technology (ART). Unlike traditional in vitro fertilization (IVF) methods that require 10-14 days of high-dose hormonal stimulation to mature eggs, It uses engineered ovarian support cells to replicate the natural egg maturation process in a laboratory setting. This innovative approach minimizes the need for hormonal injections by 80%, reduces treatment cycles to just three days, and significantly alleviates the emotional and physical strain of conventional IVF.
Dr. Dina Radenkovic, CEO and co-founder of Gameto, highlighted the transformative potential of this technology: “By overcoming the major challenges of conventional IVF, such as long treatment cycles, significant side effects, and emotional and physical strain, Fertilo provides a potentially faster, safer, and more accessible solution for families. This milestone marks a turning point in reproductive health and highlights the first application of iPSC technology in IVF.”
The Science Behind Fertilo
Fertilo leverages induced pluripotent stem cell (iPSC) technology to create ovarian support cells that co-culture with immature eggs, enhancing their maturation and embryo formation rates. This end-to-end process minimizes risks such as ovarian hyperstimulation syndrome and reduces the side effects associated with high hormone doses, making it a safer and more viable option for a broader patient population.
Dr. Luis Guzmán, Lead at Pranor Labs & Science, who oversaw the Fertilo-enabled IVF cycle, explained, “The ability to mature eggs outside the body with minimal hormonal intervention significantly reduces risks and alleviates the side effects caused by high hormone doses. Fertilo is a major advancement for women who cannot tolerate or do not want to undergo the burden of traditional IVF protocols.”
Real-Life Impact of Fertilo: World’s First Mother’s Testimony
The mother of the first baby born through Fertilo shared her experience: “The Fertilo method was the preferred option compared to traditional approaches. With fewer injections and a gentler, less invasive egg retrieval process, it gave me hope and reassurance during a deeply personal journey. Gameto’s innovative approach made the physical experience easier and also lightened the emotional burden of many hormone injections. I am profoundly grateful to the Pranor Clinic and the Gameto team for their care and dedication in making my dream of having a family a reality.”
Fertilo, A groundbreaking procedure introduced by Gameto
Gameto is a biotechnology startup dedicated to transforming women’s health through innovative treatment solutions. With a mission to make fertility treatments safer, shorter, and more accessible, Gameto’s lead program, Fertilo, represents a revolutionary step in IVF and egg-freezing technologies.
Gameto, led by CEO Dr. Dina Radenkovic, a physician-turned-entrepreneur, and Chairman Martin Varsavsky, a serial entrepreneur and founder of Prelude Fertility, Gameto combines cutting-edge science with a vision to empower women throughout their reproductive journeys. Headquartered in New York, Gameto continues to break barriers in the field of reproductive medicine.
Gameto is rapidly expanding the availability of Fertilo, securing regulatory clearance in markets such as Australia, Japan, Argentina, Paraguay, Mexico, and Peru. The company recently partnered with IVF Australia, a leading IVF clinic chain under the Virtus Health group, to further advance Fertilo’s reach. In the U.S., Gameto is preparing for Phase 3 trials to ensure accessibility for a wider patient population.
A New Era in Women’s Health
The Fertilo procedure is more than a technological achievement; it’s a beacon of hope for families around the world. By minimizing hormonal stimulation and maturing eggs outside the body, Gameto is revolutionizing the patient experience and outcomes in assisted reproduction. This historic first live birth demonstrates the immense potential of this groundbreaking procedure, paving the way for a future where fertility treatments are more accessible, less invasive, and profoundly life-changing.
